RESUMO
ETHNOPHARMACOLOGICAL RELEVANCE: According to traditional Chinese medicine (TCM) theory, cholestasis belongs to category of jaundice. Artemisia capillaris Thunb. has been widely used for the treatment of jaundice in TCM. The polysaccharides are the one of main active components of the herb, but its effects on cholestasis remain unclear. AIM OF THE STUDY: To investigate the protective effect and mechanism of Artemisia capillaris Thunb. polysaccharide (APS) on cholestasis and liver injury. MATERIALS AND METHODS: The amelioration of APS on cholestasis was evaluated in an alpha-naphthyl isothiocyanate (ANIT)-induced mice model. Then nuclear Nrf2 knockout mice, mass spectrometry, 16s rDNA sequencing, metabolomics, and molecular biotechnology methods were used to elucidate the associated mechanisms of APS against cholestatic liver injury. RESULTS: Treatment with low and high doses of APS markedly decreased cholestatic liver injury of mice. Mechanistically, APS promoted nuclear translocation of hepatic nuclear factor erythroid 2-related factor (Nrf2), upregulated downstream bile acid (BA) efflux transporters and detoxifying enzymes expression, improved BA homeostasis, and attenuated oxidative liver injury; however, these effects were annulled in Nrf2 knock-out mice. Furthermore, APS ameliorated the microbiota dysbiosis of cholestatic mice and selectively increased short-chain fatty acid (SCFA)-producing bacteria growth. Fecal microbiota transplantation of APS also promoted hepatic Nrf2 activation, increased BA efflux transporters and detoxifying enzymes expression, ameliorated intrahepatic BA accumulation and cholestatic liver injury. Non-targeted metabolomics and in vitro microbiota culture confirmed that APS significantly increased the production of a microbiota-derived SCFA (butyric acid), which is also able to upregulate Nrf2 expression. CONCLUSIONS: These findings indicate that APS can ameliorate cholestasis by modulating gut microbiota and activating the Nrf2 pathway, representing a novel therapeutic approach for cholestatic liver disease.
Assuntos
Artemisia , Colestase , Microbioma Gastrointestinal , Icterícia , Camundongos , Animais , Fator 2 Relacionado a NF-E2/metabolismo , Fígado , Colestase/induzido quimicamente , Transdução de Sinais , Icterícia/metabolismo , Ácidos e Sais Biliares/metabolismoRESUMO
Cholelithiasis is a common and frequently occurring disease worldwide that belongs to the category of jaundice in traditional Chinese medicine. Yinchenhao decoction (YD) consists of Artemisia capillaris Thunb., Gardenia jasminoides J.Ellis, and Rheum palmatum L., and is traditionally used to treat jaundice, which has a significant therapeutic effect on cholelithiasis. Our study aimed to investigate the pathological mechanism of cholelithiasis and the therapeutic mechanism of YD via mucin in the gallbladder and intestine. YD was prepared and analyzed using HPLC. The supersaturation stability experiment was designed by the solvent-shift method. The cell transport experiment was conducted by coculture monolayers. The animal experiment was performed using a cholelithiasis model with a high-cholesterol diet. The related indicators were detected by automatic biochemical analyzer, PCR, western blot, or ELISA. Statistics were analyzed using χ2-tests and t-tests. As the results, in cholelithiasis, MUC5AC highly expressed in the gallbladder shortened cholesterol supersaturation and promoted cholesterol crystallization via the inflammatory cytokine signaling pathway; MUC2 highly expressed in the small intestine prolonged cholesterol supersaturation and promoted cholesterol absorption via the inflammatory cytokine signaling pathway. YD inhibited mucin expression in the gallbladder and intestine in a concentration-dependent manner for cholelithiasis treatment by inhibiting the inflammatory cytokine signaling pathway, which was attributed to the active components, including chlorogenic acid, geniposide, and rhein.
Assuntos
Colelitíase , Medicamentos de Ervas Chinesas , Icterícia , Animais , Vesícula Biliar/química , Vesícula Biliar/metabolismo , Mucinas/metabolismo , Estrutura Molecular , Colelitíase/tratamento farmacológico , Colelitíase/química , Colelitíase/metabolismo , Colesterol/metabolismo , Icterícia/metabolismo , Intestinos/química , Citocinas/metabolismoRESUMO
OBJECTIVE: Hemolysis, icterus, and lipemia (HIL) of blood samples have been a concern in hospitals because they reflect pre-analytical processes' quality control. However, very few studies investigate the influence of patients' gender, age, and department, as well as sample-related turnaround time, on the incidence rate of HIL in fasting serum biochemistry specimens. METHODS: A retrospective, descriptive study was conducted to investigate the incidence rate of HIL based on the HIL index in 501,612 fasting serum biochemistry specimens from January 2017 to May 2018 in a tertiary university hospital with 4,200 beds in Sichuan, southwest China. A subgroup analysis was conducted to evaluate the differences in the HIL incidence rate by gender, age and department of patients, and turnaround time of specimens. RESULTS: The incidence rate of hemolysis, lipemia and icterus was 384, 53, and 612 per 10,000 specimens. The male patients had a significantly elevated incidence of hemolysis (4.13% vs. 3.54%), lipemia (0.67% vs. 0.38%), and icterus (6.95% vs. 5.43%) than female patients. Hemolysis, lipemia, and icterus incidence rate were significantly associated with the male sex with an odds ratio (OR) of 1.174 [95% confidence interval (CI), 1.140-1.208], 1.757 (95%CI: 1.623-1.903), and 1.303 (95%CI: 1.273-1.333), respectively, (P<0.05). The hospitalized patients had a higher incidence of hemolysis (4.03% vs. 3.54%), lipemia (0.63% vs. 0.36%), and icterus (7.10% vs. 4.75%) than outpatients (P<0.001). Specimens with relatively longer transfer time and/or detection time had a higher HIL incidence (P<0.001). The Pediatrics had the highest incidence of hemolysis (16.2%) with an adjusted OR (AOR) of 4.93 (95%CI, 4.59-5.29, P<0.001). The Neonatology department had the highest icterus incidence (30.1%) with an AOR of 4.93 (95%CI: 4.59-5.29, P<0.001). The Neonatology department (2.32%) and Gastrointestinal Surgery (2.05%) had the highest lipemia incidence, with an AOR of 1.17 (95%CI: 0.91-1.51) and 4.76 (95%CI: 4.70-5.53), both P-value <0.001. There was an increasing tendency of hemolysis and icterus incidence for children under one year or adults aged more than 40. CONCLUSION: Evaluation of HIL incidence rate and HIL-related influence factors in fasting serum biochemistry specimens are impartment to interpret the results more accurately and provide better clinical services to patients.
Assuntos
Jejum/metabolismo , Hemólise/fisiologia , Hiperlipidemias/metabolismo , Icterícia/metabolismo , Fenômenos Fisiológicos Sanguíneos , China , Jejum/sangue , Jejum/fisiologia , Feminino , Testes Hematológicos , Humanos , Hiperlipidemias/sangue , Hiperlipidemias/fisiopatologia , Incidência , Icterícia/sangue , Icterícia/fisiopatologia , Masculino , Estudos Retrospectivos , Manejo de Espécimes/métodosRESUMO
A 52 year old previously healthy woman from Mumbai presented with fever and jaundice of 10 days duration. At admission, she was jaundiced with tachycardia, tachypnea, hypoxia, hypotension, conjunctival congestion and mild erythematous flush over the skin. She had very high WBC counts and CRP's with direct hyperbilirubinemia and azotemia. Investigations for infectious causes of fever were negative. RT-PCR for SARS-CoV-2 in the nasopharynx was negative. However her SARS-CoV-2 antibodies were reactive. She also had echocardiographic and biochemical evidence of cardiac dysfunction. The diagnosis of Multisystem inflammatory syndrome-Adult (MIS-A) was thus established. She rapidly improved with intravenous immunoglobulin (2â¯gm/kg) and high dose steroids.
Assuntos
Febre/etiologia , Icterícia/etiologia , Azotemia/tratamento farmacológico , Azotemia/metabolismo , Azotemia/microbiologia , COVID-19/microbiologia , Ecocardiografia , Febre/tratamento farmacológico , Febre/metabolismo , Humanos , Hiperbilirrubinemia/tratamento farmacológico , Hiperbilirrubinemia/metabolismo , Hiperbilirrubinemia/microbiologia , Imunoglobulinas/uso terapêutico , Icterícia/tratamento farmacológico , Icterícia/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , SARS-CoV-2/efeitos dos fármacos , SARS-CoV-2/patogenicidade , Esteroides/metabolismoAssuntos
Atresia Biliar/diagnóstico , Atresia Biliar/fisiopatologia , Negro ou Afro-Americano , Criança , Colangiografia/métodos , Fraturas Múltiplas , Humanos , Lactente , Recém-Nascido , Icterícia/metabolismo , Icterícia Neonatal , Fígado/patologia , Masculino , Transtornos do Sono-Vigília , Baço/patologiaRESUMO
Unstable hemoglobin (Hb) variants are a rare etiology of congenital jaundice caused by hemolytic anemia. For infant patients with jaundice this disorder is often under diagnosed or the last consideration. We report a 14-month-old boy, who presented with a long-standing jaundice. His diagnosis of Hb Sabine [ß91(F7)LeuâPro; HBB: c.275T > C] was not revealed until gene sequencing of the ß-globin gene was performed.
Assuntos
Predisposição Genética para Doença , Variação Genética , Hemoglobinas/genética , Icterícia/genética , Icterícia/metabolismo , Alelos , Substituição de Aminoácidos , Biomarcadores , Análise Mutacional de DNA , Índices de Eritrócitos , Estudos de Associação Genética , Hemoglobinas/metabolismo , Hemoglobinas Anormais/genética , Humanos , Lactente , Icterícia/diagnóstico , Masculino , Mutação , Estabilidade Proteica , Globinas beta/genéticaRESUMO
Alcoholic hepatitis is a unique type of alcohol-associated liver disease characterized by acute liver inflammation caused by prolonged heavy alcohol use. Treatment is mostly supportive. The short-term prognosis of acute alcoholic hepatitis depends on liver recovery, and ranges widely from rapid improvement to grim multiorgan failure despite treatment. Refinement of scoring systems have enhanced prognostication to guide clinical decision making in alcoholic hepatitis. Recent advances in the treatment of alcoholic hepatitis have solidified corticosteroids as the cornerstone of treatment to enhance short-term survival, but not intermediate or long-term survival.
Assuntos
Alanina Transaminase/metabolismo , Aspartato Aminotransferases/metabolismo , Hepatite Alcoólica/metabolismo , Icterícia/metabolismo , Doença Aguda , Biópsia , Técnicas de Imagem por Elasticidade , Glucocorticoides/uso terapêutico , Hepatite Alcoólica/diagnóstico , Hepatite Alcoólica/tratamento farmacológico , Hepatite Alcoólica/patologia , Humanos , Fígado/patologia , Prednisolona/uso terapêutico , Prognóstico , Índice de Gravidade de DoençaRESUMO
Hepatitis A is usually a benign self-limiting disease with few or no extrahepatic manifestations. Acute hepatitis A causing severe renal dysfunction is not very common, although described. Patients developing renal dysfunction post hepatitis A infection usually have prerenal acute kidney injury (AKI) or acute tubular necrosis due to vomiting, diarrhea, and poor fluid replacement. However, if renal dysfunction persists, other causes need to be evaluated. The term cholemic nephrosis or more specifically bile cast nephropathy has been described in the setting of cholestatic jaundice and decompensated liver failure where bilirubin levels reach above 20 mg/dL. Herein, we describe the clinical course of a patient who developed acute hepatitis A with severe liver dysfunction and subsequently AKI which persisted for six weeks. Renal biopsy showed the evidence of bile cast nephropathy. After six weeks of hemodialysis, urine output improved. He slowly recovered both hepatic and renal functions.
Assuntos
Injúria Renal Aguda/etiologia , Bile/metabolismo , Hepatite A/complicações , Icterícia/etiologia , Insuficiência Renal/etiologia , Doença Aguda , Injúria Renal Aguda/diagnóstico , Injúria Renal Aguda/metabolismo , Injúria Renal Aguda/terapia , Adulto , Biópsia , Hepatite A/diagnóstico , Hepatite A/virologia , Humanos , Icterícia/diagnóstico , Icterícia/metabolismo , Icterícia/terapia , Masculino , Insuficiência Renal/diagnóstico , Insuficiência Renal/metabolismo , Insuficiência Renal/terapia , Resultado do TratamentoRESUMO
Neonatal hyperbilirubinemia and the onset of bilirubin encephalopathy and kernicterus result in part from delayed expression of UDP-glucuronosyltransferase 1A1 (UGT1A1) and the ability to metabolize bilirubin. It is generally believed that acute neonatal forms of hyperbilirubinemia develop due to an inability of hepatic UGT1A1 to metabolize efficiently bilirubin for clearance through the hepatobiliary tract. Newly developed mouse models designed to study bilirubin metabolism have led to new insight into the role of the intestinal tract in controlling neonatal hyperbilirubinemia. Humanization of mice with the UGT1 locus (hUGT1 mice) and the UGT1A1 gene provide a unique tool to study the onset of hyperbilirubinemia since the human UGT1A1 gene is developmentally regulated during the neonatal period in hUGT1 mice. A new mechanism outlying developmental expression of intestinal UGT1A1 is presented and its implications in the control of neonatal hyperbilirubinemia discussed. New findings linking breast milk protection against necrotizing enterocolitis and intestinal control of UGT1A1 may help explain the contribution of breast milk toward the development of neonatal hyperbilirubinemia. Our findings outline a new model that includes an active intestinal ROS /IκB kinase/nuclear receptor corepressor 1 loop that can be applied to an understanding of breast milk-induced jaundice.
Assuntos
Animais Recém-Nascidos/metabolismo , Glucuronosiltransferase/metabolismo , Hiperbilirrubinemia Neonatal/metabolismo , Intestinos/fisiologia , Icterícia/metabolismo , Leite Humano/metabolismo , Animais , Bilirrubina/metabolismo , Modelos Animais de Doenças , Feminino , Humanos , Recém-Nascido , Fígado/metabolismo , CamundongosAssuntos
Icterícia Neonatal , Icterícia , Bilirrubina/metabolismo , Biomarcadores/metabolismo , Diagnóstico Diferencial , Humanos , Lactente , Recém-Nascido , Icterícia/diagnóstico , Icterícia/etiologia , Icterícia/metabolismo , Icterícia/terapia , Icterícia Neonatal/diagnóstico , Icterícia Neonatal/etiologia , Icterícia Neonatal/metabolismo , Icterícia Neonatal/terapia , Fatores de RiscoRESUMO
Increased serum bilirubin level is a widely used diagnostic marker for hepatic illnesses. Nevertheless, mild elevation of unconjugated serum bilirubin (such as in Gilbert syndrome) has been recently demonstrated to correlate with low risk of chronic inflammatory and/or oxidative stress-mediated diseases. In accord, a low serum bilirubin level has emerged as an important predisposing factor or a biomarker of these pathologic conditions including cardiovascular, tumour, and possibly neurodegenerative diseases. Bilirubin possesses multiple biological actions with interaction in a complex network of enzymatic and signalling pathways. The fact that the liver is the main organ controlling the bioavailability of bilirubin emphasizes the central role of this organ in human health.
Assuntos
Bilirrubina/metabolismo , Icterícia/etiologia , Humanos , Icterícia/metabolismo , Fatores SexuaisRESUMO
DDI could be caused by the inhibition of OATP-mediated hepatic uptakes. The aim of this study is to set the risk criteria for the compounds that would cause DDI via OATP inhibition at the drug discovery stage. The IC50 values of OATP inhibitors for human OATP-mediated atorvastatin uptake were evaluated in the expression system. In order to set the risk criteria for OATP inhibition, the relationship was clarified between OATP inhibitory effect and severe adverse effects of OATP substrates, rhabdomyolysis, hyperbilirubinemia and jaundice. Rhabdomyolysis would be caused in the atorvastatin AUC more than 9-fold of that at a minimum therapeutic dose. The atorvastatin AUC was 6- to 9-fold increased with the OATP inhibitors of which IC50 values were ≤1 µmol/L. Hyperbilirubinemia and jaundice would be caused with the OATP inhibitors of which IC50 values were ≤6 µmol/L. This investigation showed that the compounds with IC50 of ≤1 µmol/L would have high risk for OATP-mediated DDI that would cause severe side effects. Before the detailed analysis based on the dosage, unbound fraction in blood and effective concentration to evaluate the clinical DDI potency, this criteria enable high throughput screening and optimize lead compounds at the drug discovery stage.
Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/etiologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/metabolismo , Transportadores de Ânions Orgânicos/antagonistas & inibidores , Atorvastatina/efeitos adversos , Atorvastatina/farmacocinética , Atorvastatina/farmacologia , Linhagem Celular , Descoberta de Drogas/métodos , Células HEK293 , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Humanos , Hiperbilirrubinemia/tratamento farmacológico , Hiperbilirrubinemia/metabolismo , Icterícia/tratamento farmacológico , Icterícia/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Rabdomiólise/tratamento farmacológico , Rabdomiólise/metabolismo , RiscoAssuntos
Neoplasias dos Ductos Biliares/patologia , Biomarcadores Tumorais/metabolismo , Carcinoma/patologia , Tumores de Células Gigantes/patologia , Idoso , Neoplasias dos Ductos Biliares/metabolismo , Ductos Biliares Extra-Hepáticos/patologia , Proteínas de Ligação ao Cálcio/metabolismo , Carcinoma/metabolismo , Diagnóstico Diferencial , Tumores de Células Gigantes/metabolismo , Humanos , Icterícia/metabolismo , Icterícia/patologia , Masculino , Proteínas de Neoplasias/metabolismoRESUMO
Melatonin exerts protection in several inflammatory and neurodegenerative disorders. To investigate the neuroprotective effects of melatonin in an experimental hemolysis-induced hyperbilirubinemia, newborn Sprague-Dawley rats (25-40 g, n = 72) were injected with phenylhydrazine hydrochloride (PHZ; 75 mg/kg) and the injections were repeated at the 24th hour. Rats were treated with saline or melatonin (10 mg/kg) 30 min before the first and second PHZ injections and 24 h after the 2nd PHZ injections. Control rats (n = 24) were injected with saline, but not PHZ. At sixth hours after the last injections of saline or melatonin, all rats were decapitated. Tumor necrosis factor (TNF)-α, IL-1ß, IL-10 and brain-derived neurotrophic factor (BDNF) and S100B levels in the plasma were measured. Brain tissue malondialdehyde (MDA), glutathione (GSH) levels and myeloperoxidase (MPO) activities were measured, and brain tissues were evaluated for apoptosis by TUNEL method. In the saline-treated PHZ group, hemoglobin, hematocrit levels were reduced, and total/direct bilirubin levels were elevated when compared to control group. Increased plasma TNF-α, IL-1ß levels, along with decreased BDNF, S100B and IL-10 values were observed in the saline-treated PHZ group, while these changes were all reversed in the melatonin-treated group. Increased MDA levels and MPO activities in the brain tissues of saline-treated hyperbilirubinemic rats, concomitant with depleted brain GSH stores, were also reversed in the melatonin-treated hyperbilirubinemic rats. Increased TUNEL(+) cells in the hippocampus of saline-treated PHZ group were reduced by melatonin treatment. Melatonin exerts neuroprotective and anti-apoptotic effects on the oxidative neuronal damage of the newborn rats with hemolysis and hyperbilirubinemia.
Assuntos
Apoptose/efeitos dos fármacos , Lesões Encefálicas/prevenção & controle , Icterícia/tratamento farmacológico , Melatonina/farmacologia , Fármacos Neuroprotetores/farmacologia , Animais , Lesões Encefálicas/metabolismo , Lesões Encefálicas/patologia , Citocinas/metabolismo , Modelos Animais de Doenças , Icterícia/metabolismo , Icterícia/patologia , Proteínas do Tecido Nervoso/metabolismo , Oxirredução/efeitos dos fármacos , Ratos , Ratos Sprague-DawleyRESUMO
OBJECTIVE: To study the daily administration times of Canhuang tablet (CHT) for treating jaundice in rats based on a pharmacodynamic/pharmacokinetic model. METHODS: Rats were modeled by 4% 1-Naphthylisothiocyanate (75 mg/kg, p.o.). After 48 h, CHT was given (p.o.) at 0.75 g/kg once a day, 0.375 g/kg twice a day, and 0.25 g/kg three times a day. Blood was collected from the orbital sinus at different intervals. Levels of liver enzymes and bilirubin were detected using these blood samples. Bile was collected and determined after the first administration of CHT. High-performance liquid chromatography was used to determine the concentration of berberine in bile simultaneously. Time-effect and time-dose curves were then obtained. RESULTS: Compared with rats taking CHT twice and three times a day, the total amount of bile within 10 h of rats taking CHT once a day were 1.32- and 1.47-fold higher, respectively. There was good consistency between the pharmacokinetics of berberine and the pharmacodynamics of the effect on liver enzymes and bilirubin in vivo. The pharmacokinetic analyses showed that rats administered CHT once daily maintained a higher concentration of berberine in bile for a longer period than rats administered CHT two- and three-times daily. CONCLUSION: In jaundiced rats, taking CHT once a day is better than taking CHT twice or three times a day. These data may provide a reference for the clinical application of CHT.
Assuntos
Medicamentos de Ervas Chinesas/administração & dosagem , Icterícia/tratamento farmacológico , Animais , Bilirrubina/metabolismo , Modelos Animais de Doenças , Medicamentos de Ervas Chinesas/farmacocinética , Feminino , Humanos , Icterícia/metabolismo , Masculino , Ratos , Ratos Wistar , Comprimidos/administração & dosagemRESUMO
BACKGROUND/PURPOSE: Biliary atresia (BA) causes biliary obstruction in neonates. Although the Kasai operation can successfully treat certain BA cases, many patients exhibit recurrent jaundice and secondary biliary cirrhosis requiring liver transplantation. Consequently, studies of the prognostic factors of the Kasai operation are needed. Accordingly, sonic hedgehog (SHH) pathway expression at the extrahepatic bile duct (EHBD), an important bile duct repair mechanism, will be investigated via immunohistochemistry in patients with BA to examine the association with post-Kasai operation prognosis. METHODS: Fifty-seven EHBD specimens were obtained during Kasai operations from 1992 to 2009. The SHH, patched (PTCH), and glioblastoma-2 (Gli-2) immunohistochemical staining results were analyzed quantitatively. RESULTS: Overall, 57.9% of patients had bile flow normalization after the Kasai operation; 43.1% did not. High preoperative serum total bilirubin, direct bilirubin, and aspartate aminotransferase levels were associated with sustained jaundice post-Kasai operation, as was an age ≥65days at the time of surgery (all p<0.05). High Gli-2 and SHH expression rates were significantly associated with early post-Kasai operation jaundice relapse. CONCLUSION: Strong Gli-2 and SHH expression in the EHBD might be a poor prognostic factor in Kasai operation-treated patients with BA.
Assuntos
Atresia Biliar/metabolismo , Proteínas Hedgehog/biossíntese , Icterícia/metabolismo , Fatores de Transcrição Kruppel-Like/biossíntese , Proteínas Nucleares/biossíntese , Atresia Biliar/complicações , Biomarcadores/metabolismo , Pré-Escolar , Intervalo Livre de Doença , Feminino , Humanos , Imuno-Histoquímica , Lactente , Recém-Nascido , Icterícia/etiologia , Masculino , Prognóstico , Estudos Retrospectivos , Proteína Gli2 com Dedos de ZincoAssuntos
Dor Abdominal/etiologia , Ascite/etiologia , Cisto do Colédoco/complicações , Icterícia/etiologia , Dor Abdominal/diagnóstico , Ascite/diagnóstico , Ascite/metabolismo , Bile/metabolismo , Colangiopancreatografia por Ressonância Magnética , Cisto do Colédoco/diagnóstico , Cisto do Colédoco/metabolismo , Cisto do Colédoco/cirurgia , Humanos , Lactente , Icterícia/diagnóstico , Icterícia/metabolismo , Ruptura Espontânea , Resultado do TratamentoRESUMO
BACKGROUND: Hemolysis, icterus, and lipemia (HIL) cause preanalytical interference and vary unpredictably with different analytical equipments and measurement methods. We developed an integrated reporting system for verifying HIL status in order to identify the extent of interference by HIL on clinical chemistry results. METHODS: HIL interference data from 30 chemical analytes were provided by the manufacturers and were used to generate a table of clinically relevant interference values that indicated the extent of bias at specific index values (alert index values). The HIL results generated by the Vista 1500 system (Siemens Healthcare Diagnostics, USA), Advia 2400 system (Siemens Healthcare Diagnostics), and Modular DPE system (Roche Diagnostics, Switzerland) were analyzed and displayed on physicians' personal computers. RESULTS: Analytes 11 and 29 among the 30 chemical analytes were affected by interference due to hemolysis, when measured using the Vista and Modular systems, respectively. The hemolysis alert indices for the Vista and Modular systems were 0.1-25.8% and 0.1-64.7%, respectively. The alert indices for icterus and lipemia were <1.4% and 0.7% in the Vista system and 0.7% and 1.0% in the Modular system, respectively. CONCLUSIONS: The HIL alert index values for chemical analytes varied depending on the chemistry analyzer. This integrated HIL reporting system provides an effective screening tool for verifying specimen quality with regard to HIL and simplifies the laboratory workflow.
Assuntos
Análise Química do Sangue/métodos , Hemólise , Hiperlipidemias/patologia , Icterícia/patologia , Análise Química do Sangue/instrumentação , Análise Química do Sangue/normas , Feminino , Hemoglobinas/análise , Humanos , Hiperlipidemias/metabolismo , Icterícia/metabolismo , Masculino , Controle de Qualidade , Reprodutibilidade dos TestesRESUMO
Weil's disease, the most severe form of leptospirosis, is characterized by jaundice, haemorrhage and renal failure. The mechanisms of jaundice caused by pathogenic Leptospira remain unclear. We therefore aimed to elucidate the mechanisms by integrating histopathological changes with serum biochemical abnormalities during the development of jaundice in a hamster model of Weil's disease. In this work, we obtained three-dimensional images of infected hamster livers using scanning electron microscope together with freeze-cracking and cross-cutting methods for sample preparation. The images displayed the corkscrew-shaped bacteria, which infiltrated the Disse's space, migrated between hepatocytes, detached the intercellular junctions and disrupted the bile canaliculi. Destruction of bile canaliculi coincided with the elevation of conjugated bilirubin, aspartate transaminase and alkaline phosphatase levels in serum, whereas serum alanine transaminase and γ-glutamyl transpeptidase levels increased slightly, but not significantly. We also found in ex vivo experiments that pathogenic, but not non-pathogenic leptospires, tend to adhere to the perijunctional region of hepatocyte couplets isolated from hamsters and initiate invasion of the intercellular junction within 1 h after co-incubation. Our results suggest that pathogenic leptospires invade the intercellular junctions of host hepatocytes, and this invasion contributes in the disruption of the junction. Subsequently, bile leaks from bile canaliculi and jaundice occurs immediately. Our findings revealed not only a novel pathogenicity of leptospires, but also a novel mechanism of jaundice induced by bacterial infection.